From: New evidences on the altered gut microbiota in autism spectrum disorders
 | Autistic | Neurotypical |
---|---|---|
Subjects (n) | 40 | 40 |
Age (1st–3rd quartile) | 10 (5–17) | 7 (3.6–12) |
Gender (n) | ||
 Female | 22.5% (9) | 30% (12) |
 Male | 77.5% (31) | 70% (28) |
Constipation (n) | ||
 Constipated | 12.5% (5) | 27.5% (11) |
 Non-constipated | 72.5% (29) | 72.5% (29) |
 NA | 15% (6) | 0% (0) |
Calprotectin (1st–3rd quartile) | 36.9 (17.6–76.0) μg/g | 40.9 (17–74.7) μg/g |
 Constipated | 39.1 (22.9–70.0) μg/g | 27.9 (20.3–97.6) μg/g |
 Non-constipated | 35.9 (15.0–57.8) μg/g | 50.5 (15.0–73.8) μg/g |
CARS (1st–3rd quartile) | 47 (40–50.5) | NA |
 Constipated | 50 (36–52.0) | NA |
 Non-constipated | 48 (42–50.0) | NA |
ESR (1st–3rd quartile) | 7.5 (3.25–17.7) mm/h | NA |
 Constipated | 22.0 (12.0–25.0) mm/h | NA |
 Non-constipated | 7.0 (2.7–11.2) mm/h | NA |
Serum IgA (1st–3rd quartile) | 131.0 (70.0–172.2) mg/ml | NA |
 Constipated | 97.0 (82.0–153.0) mg/ml | NA |
 Non-constipated | 133.0 (67.0–181.0) mg/ml | NA |